Interaction of aldose reductase and superoxide dismutase activity in liver; influence of vasopressin hormone and its modulators
DOI:
https://doi.org/10.7439/ijbr.v6i10.2600Keywords:
Labia Major, Rhabdomyosarcoma (RMS), Alveolar Rhabdomyosarcoma (ARMS), vulvaAbstract
The Liver is an important organ of the body for carbohydrate metabolism which include ureogenesis, glycogenolysis, gluconeogenesis. The pituitary hormone vasopressin mediates its actions on the carbohydrate metabolism through the V1 receptors expressed in the Liver. The vasopressin V1 receptors are coupled to the phospholipase C mediated signalling pathway. In this article, the focus is on the effects of vasopressin on superoxide dismutase (SOD) and Aldose reductase (ALD) enzyme activity in the Liver. It also stresses on the role of calcineurin phosphatase which may be involved in ROS generation. The possible homeostatic balance between superoxide generation and polyol pathway during liver injury and the role of vasopressin hormone is also discussedDownloads
References
Valtin H. Genetic models of diabetes insipidus. In: Windhager E E, editor. Handbook of physiology. Section 8: renal physiology. II. Bethesda, Md: American Physiology Society. 1992; 1281
Drew, P.J.T., Monson, J. P., Metcalfe, H. K., Evans, S.J.W., Iles, R. A., Cohen, R. D. The effect of arginine vasopressin on ureagenesis in isolated rat hepatocytes. Clin. Sci. 1985 ; 69 : 231
Kraus-Friedmann, N., Feng, L. The role of intracellular Ca2+ in the regulation of gluconeogenesis. Metabolism.1996; 45: 389
Buetler T M, Krauskopf A, Ruegg UT. Role of Superoxide as a Signaling Molecule. News Physiol. Sci. 2004; 19 (3) :120-123
Ryter S W,Hong PK , Hoetzel A, Wong X, Choi AMK.Mechanisms of cell death in oxidative stress. In Antioxidants and Redox Signaling. 2007; 9(1) : 49
Allen, R G., and Tresini, M. Oxidative stress and gene regulation. Free Radic. Biol. Med. 2000; 28: 463
Ullrich V, Zou M H, and Bachschmid M. New physiological and pathophysiological aspects on the thromboxane A (2)-prostacyclin regulatory system. Biochim. Biophys. Acta. 2001; 532: 1
Hers H G. The mechanism of transformation of glucose to fructose by the seminal vesicles. Biochim Biophys Acta. 1956; 22:202
Pugliese G, Tilton R G, Williamson J R. Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev. 1991; 7:35
Kinoshita J H, Nishimura C. The involvement of aldose reductase in diabetic complications. Diabetes Metab Rev. 1988;4:323
Del Corso A, Camici M, Mura U. In vitro modification of bovine lens aldose reductase activity. Biochem Biophys Res Commun. 1987; 148(1): 369-75.
Schade SZ, Early SL, Williams TR, K
Suzen S, Das-Evcimen N, Varol P, Sar?kaya M.Preliminary evaluation of rat kidney aldose reductase inhibitory activity of 2-phenylindole derivatives: affiliation to antioxidant activity. Medicinal Chemistry Research. 2007; 16 (3): 112-118.
Gabbay K H. Hyperglycemia, polyol metabolism, and complications of diabetes mellitus. Annu Rev Med. 1975; 26:521-36.
Gui T, Tanimoto T, Kokai Y, Nishimura C. Presence of a closely related subgroup in the aldo-ketoreductase family of the mouse. Eur J Biochem. 1995; 227(1-2):448-53.
Alexiou P, Pegklidou K, Chatzopoulou M, Nicolaou I, Demopoulos VJ. Aldose reductase enzyme and its implication to major health problems of the 21 (st) centuries. Curr Med Chem. 2009; 16(6):734-52.
Rondeau JM, Tete-Favier F, Podjarny A, Reymann JM, Barth P, Biellmann JF, Moras D. Novel Nadph-Binding Domain Revealed by the Crystal Structure of Aldose Reductase. Nature. 1992; 355(6359) 469-472.
Landis GN and Tower J. Superoxide dismutase evolution and life span regulation. In Mechanisms of Ageing and Development. 2005; 126 (3): 365
Springate J E, Feld L G, Van Liew J B, Fildes R D, Acara M A. Diuretic and natriuretic effects of sorbinil, an aldose reductase inhibitor. Pharmacol Res. 1991; 23:279
N L Ostrowski, S J Lolait, D J Bradley, A M O'Carroll, M J Brownstein, and W S Young, 3rd. Distribution of V1a and V2 vasopressin receptor messenger ribonucleic acids in rat liver, kidney, pituitary and brain. Endocrinology. 1992 Jul; 131(1):533-5.
Martin-Llahi M, Pepin MN, Guevara M, Diaz F, Torre A, Monescillo A, Soriano G, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008; 134:1352
Fabrizi F, Dixit V, Messa P, Martin P. Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials. Int J Artif Organs. 2009; 32:133
Wagener G, Gubitosa G, Renz J, Kinkhabwala M, Brentjens T, Guarrera JV, Emond J, et al. Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation. Liver Transpl. 2008;14:1664
Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med. 2001; 27:1416
Greenberg A, Verbalis JG: Vasopressin receptor antagonists. Kidney Int 2006; 69:2124-2130.
Ali F, Guglin M, Vaitkevicius P, Ghali JK: Therapeutic potential of vasopressin receptor antagonists. Drugs 2007; 67: 847-858.
Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. Journal of Gastroenterology and Hepatology, 2011; 26 (supplements 1): 173
Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant. 2011; 11:1563
Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/ reperfusion injury- a fresh look. Exp Mol Pathol. 2003; 74:86
Boros P, Bromberg JS. New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant. 2006; 6:652
Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis. 2001; 21:105
Vanderjagt DL, Hunsaker LA, Vanderjagt TJ, Gomes MS, Gonzales DM, Duk LM & Royer ME. Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes. Biochem Pharmacol. 1997; 53: 1133
Misra, H.P and I.Fridovich. The role of superoxide anion in the autooxidation of epinephrine and simple assay for superoxide dismutase. J. Biol. Chem. 1972; 247: 3170-3175.
Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T-4. Nature. 1970; 227: 680-685.
Kumar A, Margaret Shanthi F. X., Mahalaxmi C., Ramaswamy A, Bina Isaac and Tyagi MG. Rottlerin Mediated Modulation of Tonicity-Responsive Enhancer Binding Protein (TonEBP) In Wistar Rats. Biomedical & Pharmacology Journal. 2014; 7(2): 665-673.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- An author must submit Copyright form After acceptance of the article.